Status:
TERMINATED
Collection of Biological Material From Pregnant Women in a Malarial Region
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Malaria
Eligibility:
FEMALE
14-45 years
Brief Summary
Background: \- Malaria is a disease caused by a parasite that infects the blood. It affects millions of people every year and frequently harms or kills pregnant woman and infants. Researchers are loo...
Detailed Description
Malaria caused by Plasmodium falciparum continues to be a global problem with devastating consequences. Pregnancy malaria is associated with low birth weight, maternal anemia, and gestational hyperten...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:\<TAB\>
- A study participant must satisfy the following criteria to be enrolled in this study:
- Pregnant women aged 14-45 years or newborns of pregnant women enrolled at parturition
- Able to provide consent for self and newborn (if enrolled at parturition)
- EXCLUSION CRITERIA:\<TAB\>
- Clinically symptomatic or apparent severe anemia, active bleeding, or any other condition that may be worsened by 10 mL phlebotomy or any other study procedure
- History of involvement in a malaria vaccine study
Exclusion
Key Trial Info
Start Date :
February 10 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2016
Estimated Enrollment :
1270 Patients enrolled
Trial Details
Trial ID
NCT01862783
Start Date
February 10 2013
End Date
March 15 2016
Last Update
November 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kalisizo Hospital
Rakai District, Uganda